Evotec Shares Rise on Kidney Disease Pact with Astrazeneca
By Cormac Sheridan
Wednesday, October 23, 2013
Shares in Evotec AG rose 10 percent Monday on news of a research partnership with Astrazeneca plc on the discovery and development of disease-modifying drugs for chronic kidney disease.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.